Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : LH crawled time : 13:00 save search
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: 0.82%
H: 0.0%
C: 0.0%
test blood for neurodegenerative labcorp
Labcorp Declares Quarterly Dividend - April 11, 2024
Published: 2024-04-11 (Crawled : 13:00) - biospace.com/
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: -0.61%
H: 0.02%
C: -0.68%
labcorp
The Prelude Network® Names Labcorp Its Preferred Genetic Carrier Screening Lab
Published: 2024-03-29 (Crawled : 13:00) - prnewswire.com
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
| Email alert
Add to watchlist
network genetic
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board
Published: 2024-02-21 (Crawled : 13:00) - globenewswire.com
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: -0.17%
H: 1.3%
C: 1.22%
BMRA | $0.751 0.0% 55K
|
Health Technology
|
| O: 2.44%
H: 3.81%
C: 2.86%
diagnostics
Labcorp Announces 2023 Fourth Quarter and Full Year Results
Published: 2024-02-15 (Crawled : 13:00) - biospace.com/
FTRE | $36.02 -1.34% -1.36% 680K
|
n/a
|
| O: 0.56%
H: 2.89%
C: 2.28%
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: -0.49%
H: 1.08%
C: -2.15%
year results
Labcorp Named One of the World's Most Admired Companies™ by FORTUNE® Magazine
Published: 2024-02-01 (Crawled : 13:00) - biospace.com/
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: -1.81%
H: 2.77%
C: 2.75%
fortune one
Labcorp Declares Quarterly Dividend - January 12, 2024
Published: 2024-01-12 (Crawled : 13:00) - biospace.com/
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: 0.14%
H: 0.99%
C: 0.09%
Labcorp and Hawthorne Effect Collaborate to Bring Clinical Trials Directly to Patients and Investigators in Local Communities
Published: 2024-01-10 (Crawled : 13:00) - prnewswire.com
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: -0.03%
H: 0.7%
C: -1.21%
trials
Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease
Published: 2023-10-11 (Crawled : 13:00) - biospace.com/
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: -0.02%
H: 0.0%
C: -1.31%
disease test alzheimer's
Labcorp OnDemand Offers Menopause Test to Consumers
Published: 2023-07-24 (Crawled : 13:00) - biospace.com/
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: 0.07%
H: 0.43%
C: -0.25%
test
Labcorp Finalizes Strategic Relationship with Jefferson Health
Published: 2023-07-13 (Crawled : 13:00) - biospace.com/
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: -0.15%
H: 0.02%
C: -0.48%
health
Labcorp Announces Launch of Fortrea's Notes Offering in Connection with Anticipated Spinoff
Published: 2023-06-08 (Crawled : 13:00) - prnewswire.com
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: 0.01%
H: 0.37%
C: 0.09%
offering
Labcorp's Planned Spin-off, Fortrea, to Host 2023 Investor Day
Published: 2023-06-05 (Crawled : 13:00) - biospace.com/
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: 0.18%
H: 0.93%
C: 0.18%
day
Thomas Pike to Join Labcorp as President and Chief Executive Officer of Its Drug Development Clinical Development Business Unit
Published: 2023-01-05 (Crawled : 13:00) - biospace.com/
MLM | $587.13 -0.98% 0.0% 540K
|
Non-Energy Minerals
|
| O: -1.12%
H: 0.07%
C: -1.7%
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: -0.93%
H: 1.25%
C: 1.05%
drug
Global Hematologic Malignancies Testing Market Report 2022-2032: Technological Advancements in the Field of Hematologic Malignancies Testing Presents Opportunities
Published: 2022-07-14 (Crawled : 13:00) - prnewswire.com
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -0.15%
H: 0.02%
C: -0.6%
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: -1.23%
H: 1.47%
C: 1.28%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: -2.55%
H: 0.52%
C: -1.92%
BIO | News | $281.02 -3.38% -0.36% 370K
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: -0.8%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -0.15%
H: 0.02%
C: -0.6%
ILMN | $116.64 -1.4% -1.41% 1.8M
|
Health Technology
|
| O: -0.33%
H: 0.22%
C: -1.86%
ICLR | $291.74 -0.1% -0.1% 500K
|
Health Technology
|
| O: -1.05%
H: 0.56%
C: 0.56%
report market
Global Minimal Residual Disease (MRD) Testing Market to Reach $2.61 billion by 2027, Suggest a Latest BIS Research Study
Published: 2022-06-10 (Crawled : 13:00) - prnewswire.com
DGX | $125.91 -0.84% -0.7% 870K
|
Health Services
|
| O: -1.79%
H: 0.0%
C: 0.0%
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: -4.59%
H: 0.0%
C: 0.0%
BIO | News | $281.02 -3.38% -0.36% 370K
|
Health Technology
|
| O: -4.44%
H: 0.0%
C: 0.0%
OPK | $1.235 -1.2% -1.21% 4.1M
|
Health Technology
|
| O: -4.2%
H: 0.0%
C: 0.0%
NTRA S | $87.19 -3.48% -3.6% 1.1M
|
Health Services
|
| O: -7.01%
H: 0.0%
C: 0.0%
ICLR | $291.74 -0.1% -0.1% 500K
|
Health Technology
|
| O: -3.06%
H: 0.0%
C: 0.0%
ADPT | $2.33 -4.51% -4.72% 2.8M
|
Commercial Services
|
| O: -6.61%
H: 0.0%
C: 0.0%
research disease market test
Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and Services
Published: 2021-12-23 (Crawled : 13:00) - biospace.com/
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: 0.66%
H: 0.14%
C: -1.41%
diagnostic genomic diagnostics
Labcorp and ConcertAI Optimize Precision Oncology Research With Real-World Data and Artificial Intelligence
Published: 2021-12-01 (Crawled : 13:00) - biospace.com/
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: -2.11%
H: 2.16%
C: 0.0%
artificial intelligence research
Labcorp to Acquire Toxikon, Expanding Nonclinical Development Testing Capabilities for Pharmaceutical, Biotech and Medical Device Clients
Published: 2021-11-18 (Crawled : 13:00) - biospace.com/
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: 0.14%
H: 0.85%
C: -0.06%
test biotech device iot
Pillar Biosciences to Collaborate with Labcorp on Precision Genomic Cancer Testing Using Next-Generation Sequencing
Published: 2021-10-14 (Crawled : 13:00) - biospace.com/
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: 0.82%
H: 0.83%
C: 0.0%
test genomic cancer bioscience collaboration
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.